Monoclonal antibody benralizumab was found to be more effective than the standard treatment in a clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback